Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALVOGEN

  • FDA Approval
  • March 10, 2025, 08:39 UTC
  • 65
  • 0 comments

FDA approve PREGABALIN

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • March 10, 2025, 08:39 UTC
  • 58
  • 0 comments

FDA approve TACROLIMUS

Comment Full text

BARR

  • FDA Approval
  • March 10, 2025, 08:39 UTC
  • 56
  • 0 comments

FDA approve GALANTAMINE HYDROBROMIDE

Comment Full text

PRINSTON INC

  • FDA Approval
  • March 10, 2025, 08:39 UTC
  • 59
  • 0 comments

FDA approve ESCITALOPRAM OXALATE

Comment Full text

TORRENT

  • FDA Approval
  • March 10, 2025, 08:39 UTC
  • 64
  • 0 comments

FDA approve MINOCYCLINE HYDROCHLORIDE

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • March 10, 2025, 08:39 UTC
  • 61
  • 0 comments

FDA approve CICLOPIROX

Comment Full text

CELLTRION INC

  • FDA Approval
  • March 07, 2025, 17:33 UTC
  • 75
  • 0 comments

FDA approve OMALIZUMAB-IGEC

Comment Full text

SCIEGEN PHARMACEUTICALS INC

  • FDA Approval
  • March 07, 2025, 16:33 UTC
  • 66
  • 0 comments

FDA approve SITAGLIPTIN

Comment Full text

BIOCON PHARMA LTD

  • FDA Approval
  • March 07, 2025, 16:33 UTC
  • 63
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

AGGREGA PHARMA, LLC

  • FDA Approval
  • March 07, 2025, 16:33 UTC
  • 66
  • 0 comments

FDA approve PRUCALOPRIDE SUCCINATE

Comment Full text
  • Previous
  • 225
  • 226
  • 227
  • 228
  • 229
  • Next

Search

News categories

  • Technical Exchange News(11390)
  • Event(2916)
  • SEC News(207496)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(135265)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin